Publications found:
345
Sort by:
Dementia and Alzheimer’s Disease Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class (Cholinergic/ Cholinesterase (ChE) Inhibitors, Memantine, Combination Drugs, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Region & Competition, 2021-2031F
US$ 4,500.00
The Global market for dementia and Alzheimer's disease treatments is anticipated to expand from USD 12.18 billion in 2025 to USD 17.91 billion by 2031, reflecting a compound annual growth rate of 6.64...
May 2026
180 pages
Tardive Dyskinesia Therapeutics Market Forecasts to 2034 – Global Analysis By Product Type (Valbenazine, Deutetrabenazine, Clonazepam, Vitamin E, Benzodiazepines, Ondansetron, Tetrabenazine, Reserpine, Propranolol and Dopamine-Depleting Agents), Disease Type, Route Of Administration, Distribution Channel and By Geography
US$ 4,150.00
According to Stratistics MRC, the Global Tardive Dyskinesia Therapeutics Market is accounted for $3.4 billion in 2026 and is expected to reach $8.0billion by 2034 growing at a CAGR of 11.1% during the...
April 2026
200 pages
Selective Serotonin Reuptake Inhibitors Market Size, Share & Trends Analysis Report By Drug Type (Molecule), By Indication (Major Depressive Disorder, Anxiety Disorders, Obsessive Compulsive Disorder), By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global selective serotonin reuptake inhibitors market size was valued at USD 19.51 billion in 2025 and is projected to reach USD 30.25 billion by 2033, growing at a CAGR of 5.70% from 2026 to 2033...
April 2026
150 pages
Circadian Rhythm Sleep Treatment Market - 2025
US$ 2,999.00
The Circadian Rhythm Sleep Treatment Market was valued at USD 104.5 million in 2025 and is anticipated to reach by , at a CAGR of 0.045 from 2026 to 2032. The report delivers in-depth insights into ke...
April 2026
219 pages
Idiopathic Hypersomnia Treatment Market 2026
US$ 2,999.00
The Idiopathic Hypersomnia Treatment Market was valued at in and is anticipated to reach by , at a CAGR of xx% from 2026 to 2032. The report delivers in-depth insights into key market dynamics, includ...
April 2026
220 pages
Migraine Drugs Market Size, Share, Trends and Forecast by Treatment Type, Drug Type, Route of Administration, Distribution Channel, and Region, 2026-2034
US$ 2,999.00
The global migraine drugs market size was valued at USD 4.60 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 6.50 Billion by 2034, exhibiting a CAGR of 3.90% from 2026-...
April 2026
145 pages
Alzheimer’s Drugs Market Report by Drug Class (Donepezil, Galantamine, Rivastigmine, Memantine, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Stores, and Others), and Region 2026-2034
US$ 2,999.00
The global Alzheimer’s drugs market size reached USD 8.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 13.0 Billion by 2034, exhibiting a growth rate (CAGR) of 4.67% du...
April 2026
143 pages
Amyotrophic Lateral Sclerosis Treatment Market Size, Share, Trends and Forecast by ALS Type, Drug Type, Diagnosis Type, Treatment, Distribution Channel, and Region, 2026-2034
US$ 2,999.00
The global amyotrophic lateral sclerosis treatment market size was valued at USD 819.7 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 1,177.7 Million by 2034, exhibiti...
April 2026
137 pages
Central Nervous System (CNS) Therapeutics Market Report by Disease (Neurodegenerative Diseases, Neurovascular Diseases, CNS Trauma, Mental Health, Infectious Diseases, CNS Cancer, and Others), Application (Hospital, Clinic, Homecare, and Others), and Region 2026-2034
US$ 2,999.00
The global central nervous system (CNS) therapeutics market size reached USD 157.0 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 261.0 Billion by 2034, exhibiting a gro...
April 2026
146 pages
Huntington's Disease Treatment Market Size, Share, Trends and Forecast by Type, Drug Type, Age, Distribution Channel, End User, and Region, 2026-2034
US$ 2,999.00
The global Huntington’s disease treatment market size was valued at USD 679.3 Million in 2025. Looking forward, IMARC Group estimates the market to reach USD 2,829.2 Million by 2034, exhibiting a CAGR...
April 2026
142 pages
Narcolepsy Drugs Market Report by Type (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, Secondary Narcolepsy), Disease Type (Daytime Extreme Sleepiness, Cataplexia, and Others), Therapeutic Type (Sodium Oxybate, Central Nervous System Stimulants, Tricyclic Antidepressants, Selective Serotonin Reuptake Inhibitor, and Others), and Region 2026-2034
US$ 2,999.00
The global narcolepsy drugs market size reached USD 3.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 6.7 Billion by 2034, exhibiting a growth rate (CAGR) of 6.38% duri...
April 2026
135 pages
Alzheimer’s Disease Therapeutics Market - 2025-2033
US$ 2,999.00
The Alzheimer’s Disease Therapeutics Market was valued at US$ 5.38 billion in 2025 and is anticipated to reach US$ 17.98 billion by 2033, at a CAGR of 0.1432 from 2026 to 2032. The report delivers in-...
March 2026
223 pages
Global Quetiapine Fumarate Tablets Market Growth 2026-2032
US$ 3,660.00
The global Quetiapine Fumarate Tablets market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Quetiapine is an antips...
March 2026
90 pages
